
Life Science Angels
Description
Life Science Angels (LSA) is a prominent angel investment group based in Sunnyvale, California, dedicated to funding early-stage life science companies. Established as a not-for-profit organization, LSA comprises accredited angel investors with deep expertise across various sectors, including biotechnology, medical devices, diagnostics, and digital health. Their primary mission is to provide crucial seed and Series A capital to innovative startups poised to make significant impacts in healthcare.
LSA typically targets companies that are beyond the concept stage, possessing a strong management team, a clear intellectual property strategy, and a well-defined path to market. The group's investment strategy often involves participating in syndicates, leveraging their network to co-invest alongside other angel groups, venture capital firms, and strategic partners. Their typical first check size ranges from $250,000 to $1,000,000, reflecting their commitment to providing meaningful early-stage capital.
Since its inception, Life Science Angels has established itself as one of the most active angel groups in the life science sector. The organization boasts a robust track record, having invested over $100 million into more than 100 companies. Beyond financial capital, LSA provides significant value through the collective expertise of its over 100 members, who offer mentorship, strategic guidance, and access to extensive industry networks, helping portfolio companies navigate the complex landscape of life science development and commercialization.
Investor Profile
Life Science Angels has backed more than 83 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 10% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, Israel, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (34%)
- Series Unknown (28%)
- Series A (23%)
- Series B (11%)
- Angel (2%)
- Series C (2%)
Country Focus
- United States (98%)
- Israel (1%)
- The Netherlands (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Medical Device
- Pharmaceutical
- Life Science
- Therapeutics
- Software
- Manufacturing
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.